Dtsch Med Wochenschr 2012; 137(49): 2574-2576
DOI: 10.1055/s-0032-1327265
Rheumatologie | Commentary
Rheumatologie
© Georg Thieme Verlag KG Stuttgart · New York

Weichteilrheumatismus/Fibromyalgiesyndrom

Neues zur Pathogenese, Diagnostik und Therapie Soft tissue pain syndromesNew insights into pathogenesis, diagnosis and treatment
S. Unger
1   Department für Innere Medizin, Neurologie und Dermatologie, Universitätsklinikum Leipzig
,
C. G. O. Baerwald
1   Department für Innere Medizin, Neurologie und Dermatologie, Universitätsklinikum Leipzig
› Author Affiliations
Further Information

Publication History

Publication Date:
27 November 2012 (online)

 
  • Literatur

  • 1 Browning M, Fletcher P, Sharpe M. Can neuroimaging help us to understand and classify somatoform disorders? A systematic and critical review. Psychosom Med 2011; 73: 173-184
  • 2 Calandre EP, Morillas-Arques P, Molina-Barea R et al. Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled study. BMC Musculoskelet Disord 2011; 12: 95
  • 3 Caro XJ, Winter EF. EEG biofeedback treatment improves certain attention and somatic symptoms in fibromyalgia: a pilot study. Appl Psychophysiol Biofeedback 2011; 36: 193-200
  • 4 Diers M, Schley MT, Rance M et al. Differential central pain processing following repetitive intramuscular proton/prostaglandin E injections in female fibromyalgia patients and healthy controls. Eur J Pain 2011; 15: 716-723
  • 5 Fitzcharles MA, Ste-Marie PA, Gamsa A et al. Opioid use, misuse, and abuse in patients labeled as fibromyalgia. Am J Med 2011; 124: 955-960
  • 6 Fiz J, Duran M, Capella D et al. Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life. PLoS One 2011; 6: e18440
  • 7 Hauser W, Kosseva M, Uceyler N et al. Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta-analysis. Arthritis Care Res (Hoboken) 2011; 63: 808-820
  • 8 Robinson ME, Craggs JG, Price DD et al. Gray matter volumes of pain-related brain areas are decreased in fibromyalgia syndrome. J Pain 2011; 12: 436-443
  • 9 Rohn TA, Ralvenius WT, Paul J et al. A virus-like particle-based anti-nerve growth factor vaccine reduces inflammatory hyperalgesia: potential long-term therapy for chronic pain. J Immunol 2011; 186: 1769-1780
  • 10 Russell IJ. Future perspectives in generalised musculoskeletal pain syndromes. Best Pract Res Clin Rheumatol 2011; 25: 321-331
  • 11 Smith HS, Harris R, Clauw D. Fibromyalgia: an afferent processing disorder leading to a complex pain generalized syndrome. Pain Physician 2011; 14: E217-E245
  • 12 Trelle S, Reichenbach S, Wandel S et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 2011; 342 DOI: c7086.
  • 13 Vandenkerkhof EG, Macdonald HM, Jones GT et al. Diet, lifestyle and chronic widespread pain: results from the 1958 British Birth Cohort Study. Pain Res Manag 2011; 16: 87-92
  • 14 Xiao Y, He W, Russell IJ. Genetic polymorphisms of the beta2-adrenergic receptor relate to guanosine protein-coupled stimulator receptor dysfunction in fibromyalgia syndrome. J Rheumatol 2011; 38: 1095-1103
  • 15 Themenheft „Fibromyalgiesyndrom“ – Eine interdisziplinäre S3-Leitlinie. Hintergründe und Ziele – Methodenreport – Klassifikation – Pathophysiologie – Behandlungsgrundsätze und verschiedene Therapieverfahren. Der Schmerz 2012;